Search

Your search keyword '"Dilatation, Pathologic blood"' showing total 76 results

Search Constraints

Start Over You searched for: Descriptor "Dilatation, Pathologic blood" Remove constraint Descriptor: "Dilatation, Pathologic blood"
76 results on '"Dilatation, Pathologic blood"'

Search Results

1. Association of remnant cholesterol with coronary artery ectasia: a cross-sectional study.

2. Autoimmune reactivity is present in patients with incident coronary artery ectasia.

3. Endothelial dysfunction in patients with myocardial ischemia or infarction and nonobstructive coronary arteries.

4. Carotid Intima Media Thickness and Its Association With Total Bilirubin Levels in Patients With Coronary Artery Ectasia.

5. Association between serum adropin levels and isolated coronary artery ectasia in patients with stable angina pectoris.

6. Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients.

7. The Use of Endoscopic Ultrasound in the Evaluation of Unexplained Biliary Dilation.

8. Visfatin as marker of isolated coronary artery ectasia and its severity.

9. Comparing Serum Level of Vitamin D3 in Patients With Isolated Coronary Artery Ectasia and Normal Coronary Artery Individuals.

10. Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population.

11. Relationship Between Plasma Levels of Soluble CD40 Ligand and the Presence and Severity of Isolated Coronary Artery Ectasia.

12. Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.

13. Big endothelin-1 level is a useful marker for predicting the presence of isolated coronary artery ectasia.

14. Increased plasma asymmetric dimethylarginine level is associated with ascending aorta dilatation: a case-control study.

15. Association of serglycin levels with isolated coronary artery ectasia.

16. The Association Between α 1 -Antitrypsin and Coronary Artery Ectasia.

17. Plasma Endocan Levels in Patients With Isolated Coronary Artery Ectasia.

18. Plasma thiols and thiol-disulfide homeostasis in patients with isolated coronary artery ectasia.

19. Transcriptional expression profiles of the main proteinases and their regulators in coronary artery ectasia patients' mononuclear cells.

20. Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia.

21. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.

22. SERUM LEVELS OF ENDOTHELIAL MONOCYTE ACTIVATING PEPTIDE II IN TYPE 1 DIABETES.

23. Neutrophil serine proteases and their endogenous inhibitors in coronary artery ectasia patients.

24. Is there a correlation between coronary artery ectasia and neutrophil-lymphocyte ratio?

25. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy.

26. Development of a safety biomarker signature to detect hepatic sinusoidal dilation associated with an anti-DLL4 biotherapeutic.

27. Evaluation and analysis of plasma soluble adhesion molecules in patients with coronary ectasia and atherosclerotic coronary artery disease.

28. Significance of red cell distribution width measurement for the patients with isolated coronary artery ectasia.

29. Association of red cell distribution width with the presence of coronary artery ectasia.

30. Levels of serum 25-hydroxy-vitamin d in benign and malignant breast masses.

31. Coronary artery ectasia and inflammatory cytokines: link with a predominant Th-2 immune response?

32. No relevant association between coronary artery ectasia and mean platelet volume, gamma-glutamyltransferase and uric acid levels.

33. [Relation of neutrophil/lymphocyte ratio with the presence and severity of coronary artery ectasia].

34. Association of neutrophil to lymphocyte ratio with presence of isolated coronary artery ectasia.

35. Relation of red cell distribution width with presence and severity of coronary artery ectasia.

36. Predictive value of vascular endothelial growth factor in preterm neonates with intraventricular haemorrhage.

37. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model.

38. [The relation of serum paraoxonase-1 activity with isolated coronary artery ectasia: an observational study].

39. Sonographic assessment of jugular venous distension and B-type natriuretic peptide levels in patients with dyspnoea.

40. The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

41. Assessment of red cell distribution width (RDW) in patients with coronary artery ectasia.

42. Increased plasminogen activator inhibitor-1 levels in patients with isolated coronary artery ectasia.

43. Increased epicardial adipose tissue in patients with isolated coronary artery ectasia.

44. Chronic fluoride exposure has a role in etiology of coronary artery ectasia: sialic acid/glycosaminoglycan ratio.

45. Antioxidant status and levels of antioxidant vitamins in coronary artery ectasia.

46. Lipoprotein phospholipase A2 in patients with isolated coronary artery ectasia.

47. Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone.

48. [Elevated serum uric acid levels in patients with isolated coronary artery ectasia].

49. Mean platelet volume in patients with coronary artery ectasia.

50. Chronic inflammatory status in patients with coronary artery ectasia.

Catalog

Books, media, physical & digital resources